Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Total Debt Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual total debt in 2023 was 25.59 Million PLN , down -4.59% from previous year.
Celon Pharma S.A.'s latest quarterly total debt in 2024 Q2 was 15.25 Million PLN , down -38.43% from previous quarter.
Celon Pharma S.A. reported annual total debt of 26.82 Million PLN in 2022, up 79.81% from previous year.
Celon Pharma S.A. reported annual total debt of 14.91 Million PLN in 2021, down -35.34% from previous year.
Celon Pharma S.A. reported quarterly total debt of 24.77 Million PLN for 2024 Q1, down -3.18% from previous quarter.
Celon Pharma S.A. reported quarterly total debt of 16.61 Million PLN for 2023 Q3, down -23.81% from previous quarter.

Annual Total Debt Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Total Debt of Celon Pharma S.A. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	25.59 Million PLN	-4.59%
2022	26.82 Million PLN	79.81%
2021	14.91 Million PLN	-35.34%
2020	23.07 Million PLN	1289.82%
2019	1.66 Million PLN	73.98%
2018	954.11 Thousand PLN	-71.15%
2017	3.3 Million PLN	-47.06%
2016	6.24 Million PLN	-52.66%
2015	13.19 Million PLN	209.71%
2014	4.26 Million PLN	93.78%
2013	2.19 Million PLN	0.0%
2012	- PLN	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	15.25 Million PLN	-38.43%
2024 Q1	24.77 Million PLN	-3.18%
2023 Q3	16.61 Million PLN	-23.81%
2023 Q1	27.08 Million PLN	0.97%
2023 Q4	25.59 Million PLN	54.05%
2023 FY	25.59 Million PLN	-4.59%
2023 Q2	21.8 Million PLN	-19.5%
2022 Q2	18.49 Million PLN	14.47%
2022 FY	26.82 Million PLN	79.81%
2022 Q4	26.82 Million PLN	32.09%
2022 Q1	16.16 Million PLN	8.34%
2022 Q3	20.3 Million PLN	9.77%
2021 Q2	27.1 Million PLN	1.65%
2021 Q4	14.91 Million PLN	-0.17%
2021 Q3	14.94 Million PLN	-44.87%
2021 Q1	26.66 Million PLN	15.57%
2021 FY	14.91 Million PLN	-35.34%
2020 FY	23.07 Million PLN	1289.82%
2020 Q4	23.07 Million PLN	88.55%
2020 Q3	12.23 Million PLN	441.61%
2020 Q2	2.25 Million PLN	0.0%
2020 Q1	- PLN	-100.0%
2019 Q1	988.38 Thousand PLN	3.59%
2019 FY	1.66 Million PLN	73.98%
2019 Q4	1.66 Million PLN	367.66%
2019 Q3	354.95 Thousand PLN	-33.27%
2019 Q2	531.92 Thousand PLN	-46.18%
2018 FY	954.11 Thousand PLN	-71.15%
2018 Q2	1.22 Million PLN	-58.26%
2018 Q3	976.84 Thousand PLN	-20.51%
2018 Q1	2.94 Million PLN	-10.98%
2018 Q4	954.11 Thousand PLN	-2.33%
2017 Q1	5.42 Million PLN	-13.2%
2017 Q2	1.18 Million PLN	-78.09%
2017 Q3	879.66 Thousand PLN	-25.95%
2017 Q4	3.3 Million PLN	275.91%
2017 FY	3.3 Million PLN	-47.06%
2016 FY	6.24 Million PLN	-52.66%
2016 Q4	6.24 Million PLN	-0.58%
2016 Q1	- PLN	-100.0%
2016 Q3	6.28 Million PLN	0.0%
2015 Q4	10.73 Million PLN	0.0%
2015 FY	13.19 Million PLN	209.71%
2014 FY	4.26 Million PLN	93.78%
2013 FY	2.19 Million PLN	0.0%
2012 FY	- PLN	0.0%

Peer Total Debt Comparison of Celon Pharma S.A.

Name	Total Debt	Total Debt Difference